April 24, 2019
CMS on Tuesday issued its Inpatient Prospective Payment System proposed rule for fiscal year 2020, which would address payment disparities for rural and urban health facilities and increase add-on payments for emerging technology and therapies.
As U.S. measles cases continue to surge at a record-setting pace, FDA in a statement released Monday said the measles, mumps, and rubella vaccine is safe and effective.
Intermountain Healthcare's Dixie Medical Center adopted a program to reduce infection risk among its neonatal intensive care unit patients and saw substantial improvements in patient safety and reduced operational costs.
April 23, 2019
HHS on Monday announced an initiative intended to shift primary care providers and other eligible professionals from fee-for-service payments to value-based payments using five new voluntary payment models.
Last week, Washington state Sen. Maureen Walsh (R) in a speech on the state Senate's floor said nurses at smaller rural hospitals "probably play cards for a considerable amount of the day"—sparking a wave of criticism from nurses and other health care providers. Walsh, who was arguing to exempt small rural hospitals from a bill that would require nurses to have uninterrupted breaks, later said she regretted the comment.
April 22, 2019
CMS on Friday released proposed rules that would increase fiscal year (FY) 2020 Medicare payments for skilled nursing facilities by 2.5%, or $887 million, and hospice facilities by 2.7%, or $540 million, when compared with FY 2019.
Teaching hospitals, rural hospitals, and others that serve a high proportion of dual-eligible patients faced lower penalties under Medicare's Hospital Readmissions Reduction Program in fiscal year 2019 after CMS updated how the program calculates penalties, according to a study published last week.
April 19, 2019
CMS this week released proposed rules that would increase payments for inpatient rehab facilities and inpatient psychiatric facilities by 2.3%, or $195 million, and 1.7%, or $75 million, respectively, for fiscal year 2020.
A study of 100,000 people released earlier this month shows 23andMe's genetic test would have missed identifying the increased breast cancer risk of nearly 90% of women who carry a BRCA mutation, which increases their likelihood of cancer.
American Health Line rounds up the latest health care news in the states.
Advisory Board. All rights reserved.